[Obesity and the heart]

F Barzizza1

  • 1IRCCS Policlinico San Matteo--Pavia, Presidio di Belgioioso.

Insights

Obesity independently increases heart disease risk. Weight loss improves cardiovascular health by reducing blood pressure, glucose, cholesterol, and left ventricular mass.

Area of Science:

  • Cardiology
  • Metabolic Syndrome

Context:

  • Obesity is an independent risk factor for coronary heart disease and congestive heart failure.
  • Cardiac structure and function can be altered in morbid obesity, independent of hypertension or organic heart disease.

Purpose:

  • To explore the link between obesity, cardiac dysfunction, and cardiovascular disease.
  • To understand the mechanisms of obesity cardiomyopathy and associated metabolic risk factors.

Summary:

  • Obesity leads to increased blood volume and high cardiac output, potentially causing ventricular dilatation and eccentric hypertrophy, termed obesity cardiomyopathy.
  • This can result in diastolic and systolic dysfunction, leading to congestive heart failure.
  • Central obesity, insulin resistance, and metabolic syndrome (Syndrome X) are key factors linking obesity to ischemic heart disease.

Impact:

  • Weight loss is crucial for obese patients, reducing mortality and morbidity from coronary heart disease.
  • Weight reduction can delay or prevent congestive heart failure and improve cardiac structure and function.
  • Losing weight positively impacts blood pressure, glucose levels, lipid profiles, and left ventricular mass.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...